Gainers
- Repare Therapeutics RPTX stock increased by 13.4% to $3.9 during Monday's after-market session. The company's market cap stands at $165.5 million.
- Cognition Therapeutics CGTX shares moved upwards by 10.45% to $0.52. The company's market cap stands at $20.7 million.
- Singular Genomics Sys OMIC shares rose 9.76% to $17.2. The company's market cap stands at $42.9 million.
- Vor Biopharma VOR shares increased by 5.81% to $0.74. The company's market cap stands at $50.6 million.
- Bionano Genomics BNGO stock moved upwards by 5.75% to $0.48. The market value of their outstanding shares is at $41.2 million.
- Quantum-Si QSI shares increased by 5.41% to $0.93. The company's market cap stands at $132.3 million.
Losers
- IGM Biosciences IGMS shares decreased by 15.4% to $14.0 during Monday's after-market session. The market value of their outstanding shares is at $830.4 million.
- Karyopharm Therapeutics KPTI stock decreased by 9.4% to $0.75. The market value of their outstanding shares is at $93.7 million.
- Pennant Gr PNTG stock decreased by 7.57% to $33.0. The company's market cap stands at $996.8 million.
- Apollomics APLM stock decreased by 6.26% to $0.13. The market value of their outstanding shares is at $14.6 million.
- NewGenIvf Group NIVF stock decreased by 5.0% to $0.65. The company's market cap stands at $6.5 million.
- Cue Biopharma CUE stock decreased by 5.0% to $0.72. The market value of their outstanding shares is at $34.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
BNGOBionano Genomics Inc
$0.20190.70%
CGTXCognition Therapeutics Inc
$0.6151-2.98%
CUECue Biopharma Inc
$1.01-0.98%
IGMSIGM Biosciences Inc
$6.90-2.13%
KPTIKaryopharm Therapeutics Inc
$0.6483-0.20%
NIVFNewGenIvf Group Ltd
$0.3180-6.88%
OMICSingular Genomics Systems Inc
$19.32-3.11%
PNTGPennant Group Inc
$27.380.29%
QSIQuantum-Si Inc
$1.311.55%
RPTXRepare Therapeutics Inc
$1.330.76%
VORVor Biopharma Inc
$0.90001.50%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in